Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

4,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report.
Tamura Y, Kawaoka T, Aikata H, Namba M, Fujii Y, Morio K, Murakami E, Yamauchi M, Hiramatsu A, Nakahara T, Imamura M, Maruhashi T, Kobayashi T, Ohdan H, Kimura T, Nagata Y, Arihiro K, Chayama K. Tamura Y, et al. Among authors: fujii y. Clin J Gastroenterol. 2020 Jun;13(3):421-427. doi: 10.1007/s12328-019-01075-6. Epub 2019 Nov 28. Clin J Gastroenterol. 2020. PMID: 31782114 Review.
A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.
Kosaka Y, Kawaoka T, Aikata H, Suehiro Y, Yamaoka K, Ando Y, Namba M, Takeuchi Y, Fujii Y, Uchikawa S, Kodama K, Oya K, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Baba Y, Awai K, Kimura T, Nagata Y, Chayama K. Kosaka Y, et al. Among authors: fujii y. Clin J Gastroenterol. 2020 Oct;13(5):839-843. doi: 10.1007/s12328-020-01093-9. Epub 2020 Jan 23. Clin J Gastroenterol. 2020. PMID: 31974811
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.
Yamaoka K, Kawaoka T, Aikata H, Ando Y, Kosaka Y, Suehiro Y, Fujii Y, Uchikawa S, Morio K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Takahashi S, Saeki Y, Kuroda S, Kobayashi T, Ohdan H, Miyata Y, Okada M, Chayama K. Yamaoka K, et al. Among authors: fujii y. Intern Med. 2021;60(13):2047-2053. doi: 10.2169/internalmedicine.5870-20. Epub 2021 Jul 1. Intern Med. 2021. PMID: 34193774 Free PMC article.
Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.
Naruto K, Kawaoka T, Yamasaki S, Kosaka M, Shirane Y, Johira Y, Yano S, Amioka K, Ogawa Y, Yoshikawa Y, Yamaoka K, Uchikawa S, Fujino H, Ono A, Fujii Y, Nakahara T, Murakami E, Miki D, Tsuge M, Oka S. Naruto K, et al. Among authors: fujii y. Yonago Acta Med. 2023 Nov 7;66(4):422-431. doi: 10.33160/yam.2023.11.007. eCollection 2023 Nov. Yonago Acta Med. 2023. PMID: 38028262 Free PMC article.
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma.
Kawai T, Kurokawa Y, Taguchi S, Honda K, Maki K, Ambe Y, Saegusa N, Yamamoto M, Miyakawa J, Tokura Y, Inoue H, Tanaka T, Nara K, Kaneko T, Fujii Y, Kamei J, Kakutani S, Yamada Y, Niimi A, Yamada D, Takada T, Nakagawa T, Kume H. Kawai T, et al. Among authors: fujii y. Jpn J Clin Oncol. 2025 Jan 15:hyaf001. doi: 10.1093/jjco/hyaf001. Online ahead of print. Jpn J Clin Oncol. 2025. PMID: 39812300
Development and validation of nomograms and integrated software incorporating preoperative C-reactive protein level for prognostic prediction of nonmetastatic clear cell renal cell carcinoma: Results from the International Marker Consortium for Renal Cancer (INMARC) Registry.
Chen W, Tanaka H, Kobayashi M, Fukuda S, Nakayama A, Meagher MF, Greenwald R, Schmeusser B, Nicase E, Waseda Y, Yoshida S, Derweesh IH, Master VA, Fujii Y, Saito K. Chen W, et al. Among authors: fujii y. World J Urol. 2025 Jan 9;43(1):63. doi: 10.1007/s00345-024-05421-3. World J Urol. 2025. PMID: 39786437
4,562 results